Press release year list 2023 2022 2021 2020 2019 2018 2017 2016 2014 2013
Dec 21, 2020
AbCellera-Discovered Neutralizing Antibody for COVID-19 Enters New Pragmatic Study in New Mexico
Download PDFPDF format download (opens in new window)
Dec 15, 2020
AbCellera Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
Download PDFPDF format download (opens in new window)
Dec 10, 2020
AbCellera Announces Pricing of Initial Public Offering
Download PDFPDF format download (opens in new window)
Nov 20, 2020
AbCellera-Discovered Antibody Granted Interim Authorization by Health Canada as a Treatment for COVID-19
Download PDFPDF format download (opens in new window)
Nov 19, 2020
Peter Thiel Joins AbCellera’s Board of Directors
Download PDFPDF format download (opens in new window)
Nov 19, 2020
AbCellera and Invetx Expand Multi-Year Antibody Discovery Collaboration in Animal Health
Download PDFPDF format download (opens in new window)
Nov 18, 2020
John Montalbano Joins AbCellera's Board of Directors
Download PDFPDF format download (opens in new window)
Nov 18, 2020
AbCellera Expands Technology Stack with Acquisition of Trianni for $90 Million
Download PDFPDF format download (opens in new window)
Nov 09, 2020
AbCellera-Discovered Antibody Receives U.S. FDA Emergency Use Authorization as a Monotherapy for the Treatment of COVID-19
Download PDFPDF format download (opens in new window)
Oct 29, 2020
AbCellera and Kodiak Sciences Enter Second Antibody Discovery Collaboration for Ophthalmology Targets
Download PDFPDF format download (opens in new window)
Sep 28, 2020
Fierce Biotech Names AbCellera a “Fierce 15” Company of 2020
Download PDFPDF format download (opens in new window)
Sep 24, 2020
AbCellera and IGM Biosciences Announce Multi-Year Antibody Discovery Collaboration
Download PDFPDF format download (opens in new window)
Sep 16, 2020
Interim Data Reported for AbCellera-Discovered COVID-19 Antibody in Phase 2 Clinical Trials
Download PDFPDF format download (opens in new window)
Aug 20, 2020
AbCellera Acquires OrthoMab Bispecific Platform to Propel the Development of Antibody Therapies for Pharma and Biotech Partners
Download PDFPDF format download (opens in new window)
Aug 03, 2020
AbCellera Provides COVID-19 Program Update with the Start of Phase 3 Clinical Trials and the Expansion of its COVID-19 Antibody Database
Download PDFPDF format download (opens in new window)
Jul 29, 2020
AbCellera Wins Fast Company's Innovative Team of the Year Award and Is Named to the 2020 Best Workplaces for Innovators List
Download PDFPDF format download (opens in new window)
Jul 21, 2020
AbCellera Announces Agreement with Alloy Therapeutics to Integrate Access to ATX-Gx™ Humanized Mice Platform for Antibody Discovery Programs
Download PDFPDF format download (opens in new window)
Jul 10, 2020
AbCellera Files Patent Infringement Lawsuit Against Berkeley Lights, Inc.
Download PDFPDF format download (opens in new window)
Jun 01, 2020
AbCellera’s Rapid Pandemic Response Platform Contributes to the World’s First COVID-19 Clinical Trial for a Potential Monoclonal Antibody Treatment
Download PDFPDF format download (opens in new window)
May 27, 2020
AbCellera Closes $105 Million Series B Financing to Further Advance World-Leading Antibody Drug Discovery Platform
Download PDFPDF format download (opens in new window)
May 22, 2020
AbCellera Announces Multi-Year Antibody Discovery Collaboration with Lilly
Download PDFPDF format download (opens in new window)
May 03, 2020
AbCellera Receives $175.6 million from the Government of Canada to Discover Solutions for COVID-19 and Build a Manufacturing Facility for Antibody Drugs
Download PDFPDF format download (opens in new window)
Mar 12, 2020
AbCellera and Lilly to Co-develop Antibody Therapies for the Treatment of COVID-19
Download PDFPDF format download (opens in new window)
Mar 10, 2020
AbCellera Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2020
Download PDFPDF format download (opens in new window)
Feb 23, 2020
Invetx Announces $15 million Series A Financing and Industry-leading Partnerships for Animal Biopharmaceutical Development
Download PDFPDF format download (opens in new window)
Jan 28, 2020
AbCellera is mobilizing a response to the novel coronavirus outbreak as part of its DARPA P3 program
Download PDFPDF format download (opens in new window)